Skip to main content

NuGen and Caliper to Co-develop Automated Library Construction for Next-Gen Sequencing


This story was originally published Jan. 27.

NuGen Technologies and Caliper Life Sciences said last week that they will co-develop automated methods for sample prep on Caliper's Sciclone NGS Workstation.

The partners aim to enable automatic processing from a wide range of sample types, such as nucleic acids extracted from sorted cells, fine needle aspirates, formalin-fixed paraffin embedded tissue, and other limited or degraded clinical samples.

The companies will first co-develop a method for RNA-seq library construction from as little as 500 picograms of total RNA, which they expect to be available in March. The method will make use of NuGen's Ovation RNA-seq system and Encore NGS Multiplex System I and will run on Caliper's Sciclone NGS Workstation.

NuGen's CEO Elizabeth Hutt said in a statement that the company's RNA-seq system is the first kit without any requirement for poly-A selection or ribosomal RNA depletion, which "results in a more complete data set and a more comprehensive understanding of the transcriptome, including non-coding RNA."

Aside from RNA-seq library construction, the companies plan to develop automated library construction methods for other applications, including digital gene expression, whole genome, and exome sequencing.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.